Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DSTN pseudogene 1 (DSTNP1) is a processed pseudogene related to the Destrin (DSTN) gene, which encodes an actin-binding protein involved in cytoskeletal dynamics. As a processed pseudogene, DSTNP1 does not code for a functional protein but produces RNA transcripts. Recent studies indicate that such pseudogenes can influence the expression of their parental gene through mechanisms such as competing for shared microRNAs (miRNA sponging) or through RNA modifications like N6-methyladenosine (m^6A), which can modulate RNA stability[3]. In particular, DSTNP2 (another DSTN pseudogene) was shown to regulate DSTN expression via ceRNA effects and m^6A-dependent RNA degradation, suggesting that DSTNP1 may have analogous regulatory roles, though direct experimental evidence for DSTNP1's own function is lacking[3]. Pseudogenes like DSTNP1 are generally not considered therapeutic targets but may be relevant in gene expression regulatory networks.\n\nKey points:\n- DSTNP1 is a pseudogene, not a gene coding for a functional protein.\n- It is not a therapeutic target and has no direct role as a receptor, enzyme, or druggable entity.\n- Its biological role, if any, is at the RNA level (regulatory), potentially impacting the expression of DSTN via ceRNA or RNA modification mechanisms[3].\n- No known disease roles or biomarker use are established for DSTNP1.\n- The entry appears incorrect if the intent was to identify an actionable therapeutic target, as DSTNP1 is a non-coding, non-target pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DSTN pseudogene 1 (DSTNP1).